Anxiety positively linked to physical activity in COPD patients

NewsGuard 100/100 Score

By Mark Cowen, Senior medwireNews Reporter

Higher levels of anxiety are associated with increased physical activity in patients with chronic obstructive pulmonary disease (COPD), US researchers report.

In a study of 148 COPD patients, the team found that Hospital Anxiety and Depression Scales-Anxiety (HADS-A) scores were positively and independently associated with total step count per day.

"However, it is unclear whether anxious COPD patients are more restless with increased psychomotor activity as a coping mechanism or whether those with COPD who push themselves to be more physically active experience more anxiety symptoms," comment lead author Huong Nguyen (Kaiser Permanente Southern California) and colleagues in Chest.

The participants (78% men), who had a mean 42% of predicted forced expiratory volume in 1 second and few co-morbidities, were assessed for daily step counts over a 7-day period and also completed the HADS-depression, as well as the HADS-A.

The researchers found that patients with clinically relevant anxiety levels (HADS-A >8) walked an average of 1681 more steps per day than those with lower levels of anxiety.

After accounting for factors such as age, gender, disease severity, functional capacity, depression, and dyspnea, each 1-point increase in HADS-A score was associated with a corresponding increase of 288 steps taken per day.

The team also found that increased levels of depression were associated with a lower number of steps taken per day, but anxiety attenuated the negative impact of depression on total step counts.

Nguyen et al conclude that "anxiety is associated with increased daily physical activity in a selected sample of patients with COPD."

They add: "The clinical implications of these observations are interesting because anxiety as a co-morbid disorder is associated with increased mortality while increased physical activity is associated with lower mortality in patients with COPD.

"Based on our results, future COPD studies should include objective measures of physical activity and systematic evaluations for anxiety to better inform how to improve the management and clinical outcomes of these patients."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Is psilocybin safe for treating depression and anxiety?